Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters

Publication year range
1.
Genes Immun ; 16(4): 261-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25790079

ABSTRACT

The pathogenesis of coxsackieviral infection is a multifactorial process involving host genetics, viral genetics and the environment in which they interact. We have used a mouse model of Coxsackievirus B3 infection to characterize the contribution of host genetics to infection survival and to viral hepatitis. Twenty-five AcB/BcA recombinant congenic mouse strains were screened. One, BcA86, was found to be particularly susceptible to early mortality; 100% of BcA86 mice died by day 6 compared with 0% of B6 mice (P=0.0012). This increased mortality was accompanied by an increased hepatic necrosis as measured by serum alanine aminotransferase (ALT) levels (19547±10556 vs 769±109, P=0.0055). This occurred despite a predominantly resistant (C57BL/6) genetic background. Linkage analysis in a cohort (n=210) of (BcA86x C56Bl/10)F2 animals revealed a new locus on chromosome 13 (peak linkage 101.2 Mbp, lod 4.50 and P=0.003). This locus controlled serum ALT levels as early as 48 h following the infection, and led to an elevated expression of type I interferon. Another locus on chromosome 17 (peak linkage 57.2 Mbp) was significantly linked to heart viral titer (lod 3.4 and P=0.046). These results provide new evidence for the presence of genetic loci contributing to the susceptibility of mice to viral hepatitis.


Subject(s)
Coxsackievirus Infections/genetics , Enterovirus B, Human/pathogenicity , Hepatitis, Viral, Animal/genetics , Quantitative Trait Loci , Alanine Transaminase/blood , Alanine Transaminase/genetics , Animals , Genetic Linkage , Genetic Predisposition to Disease , Interferon Type I/genetics , Interferon Type I/metabolism , Mice, Inbred C57BL , Mice, Inbred Strains
2.
Sci Rep ; 5: 9219, 2015 Mar 18.
Article in English | MEDLINE | ID: mdl-25783199

ABSTRACT

The T cell specific adapter protein (TSAd) is expressed in activated T cells and NK cells. While TSAd is beginning to emerge as a critical regulator of Lck and Itk activity in T cells, its role in NK cells has not yet been explored. Here we have examined susceptibility to virus infections in a murine model using various viral infection models. We report that TSAd-deficient mice display reduced clearance of murine cytomegalovirus (MCMV) that lack the viral MHC class I homologue m157, which is critical for Ly49H-mediated NK cell recognition of infected cells. In this infection model, NK cells contribute in the early stages of the disease, whereas CD8+ T cells are critical for viral clearance. We found that mice infected with MCMV Δm157 displayed reduced viral clearance in the spleen as well as reduced proliferation in spleen NK cells and CD8+ T cells in the absence of TSAd. Though no other immunophenotype was detected in the infection models tested, these data suggests that in the absence of the Ly49H ligand activation, NK cell and CD8+ T cell responses may be compromised in TSAd-deficient mice.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Muromegalovirus/genetics , Viral Proteins/genetics , Adaptor Proteins, Signal Transducing/genetics , Animals , CD11b Antigen/metabolism , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Line , Cell Proliferation , Cytomegalovirus Infections/immunology , Cytomegalovirus Infections/veterinary , Cytomegalovirus Infections/virology , Disease Models, Animal , Flow Cytometry , Genotype , Humans , Immunophenotyping , Killer Cells, Natural/cytology , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Muromegalovirus/physiology , Mutation , Spleen/cytology , Spleen/immunology , Spleen/virology , Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism , Viral Load , Virus Replication
3.
J Am Mosq Control Assoc ; 14(2): 131-6, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9673912

ABSTRACT

When the currently used larval surveillance system (visual inspection) for the dengue vector Aedes aegypti was compared with the surveillance for the presence of eggs by ovitrapping in Port of Spain, Trinidad, it was found that the latter (39.1%) was significantly more sensitive than the visual inspection system (10.1%). At the same time, the presence of the nuisance mosquito Culex quinquefasciatus was detected in 38.4% of the households. Both Ae. aegypti and Cx. quinquefasciatus showed preference for ovipositional attractants in ovitraps: hay infusion > yeast suspension > plain tap water. Although all the socioeconomic and geographic areas produced both mosquito species in 1996, upper middle class (UMC) areas (8.6-43.4%) produced more Ae. aegypti than did lower middle class (LMC) areas (7.8-38.8%), which produced more than working class (WC) areas (3.9-29.9%). For Cx. quinquefasciatus, the order of production was reversed with WC areas (50.1%) > LMC areas (30.0%) > UMC areas (26.0%). Change in vector surveillance strategies incorporating some ovitrapping and stratified sampling are recommended for Caribbean countries.


Subject(s)
Aedes , Dengue/transmission , Insect Vectors , Animals , Culex , Female , Oviposition , Population Surveillance , Seasons , Trinidad and Tobago
4.
J Am Mosq Control Assoc ; 13(1): 18-23, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9152870

ABSTRACT

Fifteen Caribbean strains of copepods were assessed for their predation ability against mosquito larvae. Macrocyclops albidus from Nariva. Mesocyclops aspericornis from Oropouche, and Mesocyclops longisetus from E1 Socorro, Trinidad, were most effective against Aedes aegypti but not against Culex quinquefasciatus. Mesocyclops longisetus and Me. aspericornis prevented any mosquito survival over 25 wk of observation despite weekly challenges with Ae. aegypti. The copepods were tolerant to dosages of the insecticide temephos that are usually toxic to mosquito larvae. This indicated that copepods could be incorporated into an integrated control system. To determine whether pathogenic microbes might be introduced with copepods into drinking water, microbial studies were done on the copepods. These showed the presence of only Aeromonas sobria, Pseudomonas sp., Alcalignes sp., and gram-positive bacilli. Although none of these are highly pathogenic to humans, the application of these copepods has not yet been recommended for use in drinking water.


Subject(s)
Aedes , Crustacea , Dengue/prevention & control , Pest Control, Biological/methods , Animals , Caribbean Region , Culex , Insect Vectors , Larva
5.
BMJ ; 323(7306): 203-7, 2001 Jul 28.
Article in English | MEDLINE | ID: mdl-11473911

ABSTRACT

OBJECTIVES: To examine the behaviour and attitudes related to smoking and contraband tobacco products among smokers in two socially deprived areas. DESIGN: Cross sectional study with qualitative semistructured interviews, augmented by smokers' day grid. SETTING: Two areas of socioeconomic deprivation in Edinburgh. PARTICIPANTS: 50 male and 50 female smokers aged 25-40 years randomly selected from general practitioners' lists from two health centres, each located in an area of deprivation. RESULTS: Most smokers wanted to quit but felt unable to because of the importance of smoking in their daily routine and their addiction to nicotine. Strategies for maintaining consumption levels in the face of increasing cigarette prices and low income included purchasing contraband cigarettes and tobacco. Vendors were contacted through social networks, family, and friends as well as common knowledge of people and places, particularly pubs where contraband was available. Most users of contraband considered that smugglers were providing a valuable service. Purchasing contraband tobacco was viewed as rational in the face of material hardship. Many smokers criticised the government for its high tobacco taxation and the lack of local services to help them to stop smoking. CONCLUSIONS: Smokers in deprived areas perceive a lack of support to help them to stop smoking. Cigarette and tobacco smuggling is therefore viewed positively by low income smokers as a way of dealing with the increasing cost of cigarettes. Smokers in areas of deprivation may thus show little support for tackling smuggling until more action is taken to deal with the material and personal factors that make it difficult for them to quit.


Subject(s)
Crime , Health Behavior , Smoking/psychology , Tobacco Industry , Adult , Cross-Sectional Studies , Cultural Deprivation , Female , Humans , Male , Poverty Areas , Smoking/economics , Socioeconomic Factors , United Kingdom
6.
Genes Brain Behav ; 10(4): 410-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21281445

ABSTRACT

Neurocognitive dysfunction is a core feature of schizophrenia with particularly prominent deficits in verbal episodic memory. The molecular basis of this memory impairment is poorly understood and its relatedness to normal variation in memory performance is unclear. In this study, we explore, in a sample of cognitively impaired schizophrenia patients, the role of polymorphisms in seven genes recently reported to modulate episodic memory in normal subjects. Three polymorphisms (GRIN2B rs220599, GRM3 rs2189814 and PRKCA rs8074995) were associated with episodic verbal memory in both control and patients with cognitive deficit, but not in cognitively spared patients or the pooled schizophrenia sample. GRM3 and PRKCA acted in opposite directions in patients compared to controls, possibly reflecting an abnormal brain milieu and/or adverse environmental effects in schizophrenia. The encoded proteins balance glutamate signalling vs. excitotoxicity in complex interactions involving the excitatory amino acid transporter 2 (EAAT2), implicated in the dysfunctional glutamatergic signalling in schizophrenia. Double carrier status of the GRM3 and PRKCA minor alleles was associated with lower memory test scores and with increased risk of schizophrenia. Single nucleotide polymorphism (SNP) rs8074995 lies within the PRKCA region spanned by a rare haplotype associated with schizophrenia in a recent UK study and provides further evidence of PRKCA contribution to memory impairment and susceptibility to schizophrenia. Our study supports the utility of parsing the broad phenotype of schizophrenia into component cognitive endophenotypes that reduce heterogeneity and enable the capture of potentially important genetic associations.


Subject(s)
Memory Disorders/genetics , Memory/physiology , Polymorphism, Genetic , Schizophrenia/genetics , Alleles , Endophenotypes , Genotype , Haplotypes , Humans , Neuropsychological Tests , Phenotype , Protein Kinase C-alpha/genetics , Receptors, Metabotropic Glutamate/genetics , Receptors, N-Methyl-D-Aspartate/genetics , Schizophrenic Psychology
8.
Bone Marrow Transplant ; 45(5): 886-94, 2010 May.
Article in English | MEDLINE | ID: mdl-19820727

ABSTRACT

The precise effects of CD34+ cell dose on the outcome of allogeneic transplantation for aplastic anaemia (AA) are not known. Previous studies have used the total mononuclear cell count to quantify stem cell dose. We evaluated the effects of CD34+ cell dose on the clinical and haematological end points of transplantation. The transplant variables and outcome parameters on 46 patients with acquired AA were assessed by comparing low vs high CD34+ cell doses. Infusion of less than 2 x 10(6)/kg of CD34+ cells was associated with an increased incidence of graft failures (P=0.03), higher incidence of bacterial infections (P=0.006) and a delay in the engraftment of neutrophils (P=0.046). The latter was found to be an effect of stem cell source (non-PBSC) rather than the CD34+ count. Other parameters, such as plt engraftment (P=0.63), red cell (P=0.94) and plt (P=0.31) transfusion independence, chimerism, acute and chronic GVHD (P=1.0) and OS (P=0.57), were not significantly influenced by the CD34+ cell dose. These findings are different to the published studies on the relevance of CD34+ cell dose in allogeneic transplantation for haematological cancers.


Subject(s)
Anemia, Aplastic/therapy , Antigens, CD34/immunology , Stem Cell Transplantation , Adolescent , Adult , Anemia, Aplastic/immunology , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Retrospective Studies , Transplantation, Homologous , Treatment Outcome , Young Adult
13.
Genes Immun ; 8(3): 193-204, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17287827

ABSTRACT

The pathogenesis of viral myocarditis is a multifactorial process involving host genetics, viral genetics and the environment in which they interact. We have used a model of infection with coxsackievirus B3 (CVB3) to characterize the contribution of host genetics to viral myocarditis in mice of different genetic backgrounds but with a common H2 haplotype: A/J and B10.A-H2(a). Here we have used Evans blue dye as a quantitative biomarker for susceptibility to CVB3-induced myocarditis in addition to histopathological semiquantitative measures. We have found evidence of linkage between susceptibility to viral myocarditis and three loci. A locus on chromosome 1 centered on D1Mit200 was linked to sarcolemmal disruption in males (P=0.00005), a second locus on chromosome 4 centered on D4Mit81 was also linked to sarcolemmal disruption in males (P=0.0022). A third locus on distal chromosome 3 centered on D3Mit19 was linked to myocardial infiltration, with a logarithm of odds (LOD) score of 4.7 (P=0.0045), as well as sarcolemmal disruption in females (P=0.0015). These results provide strong evidence for the presence of loci contributing to the susceptibility of mice to viral myocarditis.


Subject(s)
Coxsackievirus Infections/genetics , Coxsackievirus Infections/immunology , Enterovirus B, Human , Myocarditis/genetics , Myocarditis/immunology , Animals , Chromosome Mapping , Coxsackievirus Infections/pathology , Female , Genes, MHC Class I , Genetic Linkage , H-2 Antigens/genetics , Humans , Male , Mice , Mice, Congenic , Mice, Inbred A , Myocarditis/pathology , Phenotype , Sarcolemma/pathology
14.
Diabetologia ; 49(12): 2892-9, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17096118

ABSTRACT

AIMS/HYPOTHESIS: Identification of variants predicting development of renal dysfunction would offer substantial clinical benefits. There is evidence that coding non-synonymous variants in the gene encoding paraoxonase 2 (PON2) are associated with nephropathy in both type 1 and type 2 diabetes. METHODS: We examined the relationship between variation at the C311S and A148G polymorphisms (together with PON2 intronic variant rs12704795) and indices of renal dysfunction (progression to micro- and macroalbuminuria, plasma creatinine increases) in 3,374 newly diagnosed type 2 diabetic subjects from the UK Prospective Diabetes Study followed prospectively (median 14.0 years), using proportional hazards models, adjusted for sex, ethnicity and other known or putative risk factors. RESULTS: rs12704795 genotypes were associated with differing rates of development of microalbuminuria (relative risk [RR] for CC vs AA homozygotes 0.68 [95% CI 0.54-0.87], p=0.002) but not other measures of worsening renal function. Heterozygotes for C311S were more likely to develop microalbuminuria (RR=1.31 [95% CI 1.11-1.54], p=0.001) but less likely to double creatinine levels during follow-up (RR=0.49 [95% CI 0.27-0.89], p=0.02). There was no corroboration of this latter association for related outcomes and no prior evidence supports heterosis effects at this locus. CONCLUSIONS/INTERPRETATION: We conclude that the PON2 variants typed in this study have, at best, a small effect on the risk of renal dysfunction in type 2 diabetes.


Subject(s)
Aryldialkylphosphatase/genetics , Diabetes Mellitus, Type 2/genetics , Diabetic Nephropathies/genetics , Polymorphism, Genetic , Albuminuria/genetics , Amino Acid Substitution , Blood Pressure , Creatinine/blood , Creatinine/urine , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/enzymology , Diabetic Nephropathies/blood , Diabetic Nephropathies/enzymology , Disease Progression , Ethnicity , Female , Genotype , Humans , Linkage Disequilibrium , Male , Middle Aged , Polymorphism, Single Nucleotide
15.
Ann Hum Genet ; 70(Pt 6): 726-37, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17044847

ABSTRACT

Characterisation of the interactions between susceptibility loci (epistasis) is central to a full understanding of the genetic aetiology and the molecular pathology of complex diseases. We have examined, in British and French pedigrees, evidence for epistasis between the type 2 diabetes susceptibility loci on chromosomes 1q21-25 and 10q23-26 using two complementary linkage-based approaches. Joint two-locus linkage analysis of 1q and 10q in British pedigrees provided significant evidence for interaction (P < or = 0.003) when comparing a general epistasis model with multiplicative or additive-effects-only models. Conditional linkage analysis (which models epistasis as a deviation from multiplicativity only) confirmed these findings, with significant LOD score increases at the 1q (P = 0.0002) and 10q (P = 0.0023) loci. These analyses provided sizeable reductions in the 1-LOD support intervals for both loci. Analyses of the British and French pedigrees together yielded comparable, but not enhanced, findings, with significant (P < or = 0.003) evidence for epistasis in joint two-locus linkage analysis, and during conditional linkage analysis significant increases in linkage evidence at the 1q (P = 0.0002) and 10q (P = 0.0036) loci. Our findings of epistasis nevertheless substantiate the evidence for genuine genetic effects at both loci, facilitate endeavours to fine-map these loci in population samples, and support further examination of this interaction at the nucleotide level by providing a robust prior hypothesis.


Subject(s)
Chromosomes, Human, Pair 10 , Chromosomes, Human, Pair 1 , Diabetes Mellitus, Type 2/genetics , Epistasis, Genetic , Genetic Linkage , Genetic Predisposition to Disease , White People/genetics , Genetic Variation , Humans , Pedigree
16.
Transfus Med ; 15(5): 445-8, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16202062

ABSTRACT

A 40-year-old patient, who was a Jehovah's Witness, with acute myeloid leukaemia entered remission using a chemotherapeutic based regime aided by the addition of gemtuzumab ozogamicin without requiring any blood product support. The use of gemtuzumab ozogamicin may have helped avoid fatal pancytopenia. The use of gemtuzumab ozogamicin might be considered in similar situations.


Subject(s)
Aminoglycosides/administration & dosage , Antibodies, Monoclonal/administration & dosage , Jehovah's Witnesses , Leukemia, Myeloid, Acute/drug therapy , Adult , Antibodies, Monoclonal, Humanized , Gemtuzumab , Humans , Male , Remission Induction
17.
Nucleic Acids Res ; 25(21): 4250-6, 1997 Nov 01.
Article in English | MEDLINE | ID: mdl-9336454

ABSTRACT

Although it has been demonstrated that eukaryotic cellular origins of DNA replication may harbor stimulatory elements that bind transcription factors, how these factors stimulate origin function is unknown. In Saccharomyces cerevisiae , the transcription factor Abf1p stimulates origin function of ARS121 and ARS1 . In the results presented here, an analysis of Abf1p function has been carried out utilizing LexA(BD)-Abf1p fusion proteins and an ARS 121 derivative harboring LexA DNA-binding sites. A minimal region which stimulates origin function mapped to 50 amino acids within the C-terminus of Abf1p. When tested for transcriptional activation of a LacZ reporter gene, the same LexA(BD)-Abf1p fusion protein had negligible transcriptional activation potential. Therefore, stimulation of ARS 121 may occur independently of a transcriptional activation domain. It has been previously observed that the Gal4p, Rap1p DNA-binding sites and the LexA-Gal4p fusion protein can replace the role of Abf1p in stimulating ARS 1 . Here we show that the stimulatory function of Abf1p at ARS 121 cannot be replaced by these alternative DNA-binding sites and the potent chimeric transcriptional activator LexA(BD)-Gal4(AD)p . Hence, these results strongly suggest that the Abf1p stimulation of replication may differ for ARS 121 and ARS 1 , and imply specificity in the Abf1p/ARS 121 relationship.


Subject(s)
DNA Replication/genetics , DNA-Binding Proteins/metabolism , Replication Origin/genetics , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , Transcription Factors/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Binding Sites , DNA-Binding Proteins/genetics , Mitosis , Recombinant Fusion Proteins , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Trans-Activators/metabolism , Transcription Factors/genetics , Transcriptional Activation/physiology
18.
Anaesthesia ; 51(12): 1173-5, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9038463

ABSTRACT

In order to evaluate the contribution of tubal spasm to pelvic pain following laparoscopic sterilisation, we have studied the effect of glycopyrrolate, an anticholinergic agent with antispasmodic properties, on 60 ASA 1 and 2 patients presenting as day-cases for laparoscopic sterilisation using Filshie clips. In a randomised, double-blind, controlled trial, patients received either glycopyrrolate 0.3 mg or saline intravenously prior to induction of anaesthesia. Compared with the control group, patients receiving glycopyrrolate had significantly reduced immediate postoperative pain scores (p < 0.02) and required significantly less postoperative morphine (p < 0.01). Nausea, vomiting and anti-emetic requirements were also reduced though not significantly. We conclude that glycopyrrolate 0.3 mg at induction of anaesthesia is an effective method of improving the quality of recovery after day-case laparoscopic sterilisation using clips.


Subject(s)
Glycopyrrolate/therapeutic use , Laparoscopy/adverse effects , Pain, Postoperative/prevention & control , Parasympatholytics/therapeutic use , Sterilization, Tubal/adverse effects , Adult , Ambulatory Surgical Procedures , Analgesics, Opioid/administration & dosage , Double-Blind Method , Female , Humans , Morphine/administration & dosage , Pain, Postoperative/etiology , Preanesthetic Medication
19.
Article in English | MEDLINE | ID: mdl-171385

ABSTRACT

This is a study of forty-three female residents of a continued care state psychiatric facility who were transferred from a ward for highly disturbed persons to a ward based on a geographical unit system. One year after the transfer thirty-eight patients were improved, particularly in the area of behavior symptomatology. A change in perceived expectations of both patients and staff seemed to be primarily responsible for the positive change noted.


Subject(s)
Hospital Units , Mental Disorders/therapy , Professional-Patient Relations , Adolescent , Adult , Aged , Behavior , Female , Humans , Middle Aged , Therapeutic Community
20.
J Biol Chem ; 270(27): 16153-9, 1995 Jul 07.
Article in English | MEDLINE | ID: mdl-7608180

ABSTRACT

ABF1 is a multifunctional phosphoprotein that binds specifically to yeast origins of replication and to transcriptional regulatory sites of a variety of genes. We isolated a protein kinase from extracts of Saccharomyces cerevisiae on the basis of its ability to specifically phosphorylate the ABF1 protein. Physical and biochemical properties of this kinase identify it as casein kinase II (CKII). The purified kinase has a high affinity for the ABF1 substrate as indicated by a relatively low Km value. Furthermore, when incubated with ABF1 and anti-ABF1 antibodies, the kinase forms an immunocomplex active in the phosphorylation of ABF1. Biochemical and genetic mapping localized a major site for phosphorylation at Ser-720 near the C terminus of the ABF1 protein. This serine is embedded within a domain enriched for acidic amino acid residues. A Ser-720 to Ala mutation abolishes phosphorylation by CKII in vitro. The same mutation also abolishes phosphorylation of this site in vivo, suggesting that CKII phosphorylates Ser-720 in vivo as well. Although three CKII enzymes, yeast, sea star, and recombinant human, utilize casein as a substrate with similar efficiencies, only the yeast enzyme efficiently phosphorylates the ABF1 protein. This suggests that ABF1 is a specific substrate of the yeast CKII and that this specificity may reside within one of the beta regulatory subunits of the enzyme. Thus, phosphorylation of ABF1 by yeast CKII may prove to be a useful system for studying targeting mechanisms of CKII to a physiological substrate.


Subject(s)
DNA-Binding Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/metabolism , Transcription Factors/metabolism , Casein Kinase II , DNA-Binding Proteins/genetics , DNA-Binding Proteins/isolation & purification , Mutation , Peptide Mapping , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/isolation & purification , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Serine/genetics , Serine/metabolism , Species Specificity , Substrate Specificity , Transcription Factors/genetics , Transcription Factors/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL